Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 456463, 7 pages
http://dx.doi.org/10.1155/2015/456463
Research Article

Effect of Tyrosol and Farnesol on Virulence and Antibiotic Resistance of Clinical Isolates of Pseudomonas aeruginosa

1Department of Microbiology and Immunology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt
2Department of Pharmaceutical Sciences, Faculty of Pharmacy, Princess Norah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia

Received 11 September 2015; Revised 31 October 2015; Accepted 14 December 2015

Academic Editor: Stanley Brul

Copyright © 2015 Shaymaa Hassan Abdel-Rhman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. B. Miller and B. L. Bassler, “Quorum sensing in bacteria,” Annual Review of Microbiology, vol. 55, pp. 165–199, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. B. L. Bassler, “Small talk. Cell-to-cell communication in bacteria,” Cell, vol. 109, no. 4, pp. 421–424, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Hornby, E. C. Jensen, A. D. Lisec et al., “Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol,” Applied and Environmental Microbiology, vol. 67, no. 7, pp. 2982–2992, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Chen, M. Fujita, Q. Feng, J. Clardy, and G. R. Fink, “Tyrosol is a quorum-sensing molecule in Candida albicans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 14, pp. 5048–5052, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Weber, R. Sohr, B. Schulz, M. Fleischhacker, and M. Ruhnke, “Secretion of E, E-farnesol and biofilm formation in eight different Candida species,” Antimicrob Agents Chemother, vol. 52, no. 5, pp. 1859–1861, 2008. View at Publisher · View at Google Scholar
  6. N. Décanis, N. Tazi, A. Correia, M. Vilanova, and M. Rouabhia, “Farnesol, a fungal quorum-sensing molecule triggers Candida Albicans morphological changes by downregulating the expression of different secreted aspartyl proteinase genes,” Open Microbiology Journal, vol. 5, pp. 119–126, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. S. Alem, M. D. Y. Oteef, T. H. Flowers, and L. J. Douglas, “Production of tyrosol by Candida albicans biofilms and its role in quorum sensing and biofilm development,” Eukaryotic Cell, vol. 5, no. 10, pp. 1770–1779, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. D. K. Morales and D. A. Hogan, “Candida albicans interactions with bacteria in the context of human health and disease,” PLoS Pathogens, vol. 6, no. 4, Article ID e1000886, 2010. View at Google Scholar · View at Scopus
  9. E. Carlson, “Effect of strain of Staphylococcus aureus on synergism with Candida albicans resulting in mouse mortality and morbidity,” Infection and Immunity, vol. 42, no. 1, pp. 285–292, 1983. View at Google Scholar · View at Scopus
  10. M. E. Shirtliff, B. M. Peters, and M. A. Jabra-Rizk, “Cross-kingdom interactions: Candida albicans and bacteria,” FEMS Microbiology Letters, vol. 299, no. 1, pp. 1–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. L. J. Holcombe, G. McAlester, C. A. Munro et al., “Pseudomonas aeruginosa secreted factors impair biofilm development in Candida albicans,” Microbiology, vol. 156, no. 5, pp. 1476–1485, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. L. J. Douglas, “Candida biofilms and their role in infection,” Trends in Microbiology, vol. 11, no. 1, pp. 30–36, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Neidig, A. T. Yeung, T. Rosay et al., “TypA is involved in virulence, antimicrobial resistance and biofilm formation in Pseudomonas aeruginosa,” BMC Microbiology, vol. 13, no. 1, article 77, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Bauernfeind, G. Hörl, R. Jungwirth et al., “Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis,” Infection, vol. 15, no. 4, pp. 270–277, 1987. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Hermann, J. Hermann, U. Munzel, and R. Rüchel, “Bacterial flora accompanying Candida yeasts in clinical specimens,” Mycoses, vol. 42, no. 11-12, pp. 619–627, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. El-Azizi, S. E. Starks, and N. Khardori, “Interactions of Candida albicans with other Candida spp. and bacteria in the biofilms,” Journal of Applied Microbiology, vol. 96, no. 5, pp. 1067–1073, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Nseir, E. Jozefowicz, B. Cavestri et al., “Impact of antifungal treatment on Candida-Pseudomonas interaction: a preliminary retrospective case-control study,” Intensive Care Medicine, vol. 33, no. 1, pp. 137–142, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Gibson, A. Sood, and D. A. Hogan, “Pseudomonas aeruginosa-Candida albicans interactions: localization and fungal toxicity of a phenazine derivative,” Applied and Environmental Microbiology, vol. 75, no. 2, pp. 504–513, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. J. R. Kerr, “Suppression of fungal growth exhibited by Pseudomonas aeruginosa,” Journal of Clinical Microbiology, vol. 32, no. 2, pp. 525–527, 1994. View at Google Scholar · View at Scopus
  20. J. R. Kerr, G. W. Taylor, A. Rutman, N. Høiby, P. J. Cole, and R. Wilson, “Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth,” Journal of Clinical Pathology, vol. 52, no. 5, pp. 385–387, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. D. A. Hogan and R. Kolter, “Pseudomonas-Candida interactions: an ecological role for virulence factors,” Science, vol. 296, no. 5576, pp. 2229–2232, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. D. A. Hogan, Å. Vik, and R. Kolter, “A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology,” Molecular Microbiology, vol. 54, no. 5, pp. 1212–1223, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. G. E. Pierce, “Pseudomonas aeruginosa, Candida albicans, and device-related nosocomial infections: implications, trends, and potential approaches for control,” Journal of Industrial Microbiology and Biotechnology, vol. 32, no. 7, pp. 309–318, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Cugini, M. W. Calfee, J. M. Farrow III, D. K. Morales, E. C. Pesci, and D. A. Hogan, “Farnesol, a common sesquiterpene, inhibits PQS production in Pseudomonas aeruginosa,” Molecular Microbiology, vol. 65, no. 4, pp. 896–906, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. L. S. Derengowski, C. De-Souza-Silva, S. V. Braz et al., “Antimicrobial effect of farnesol, a Candida albicans quorum sensing molecule, on Paracoccidioides brasiliensis growth and morphogenesis,” Annals of Clinical Microbiology and Antimicrobials, vol. 8, article 13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. A. Jabra-Rizk, T. F. Meiller, C. E. James, and M. E. Shirtliff, “Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 4, pp. 1463–1469, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S. H. M. Abdel-Rhman, A. M. El-Mahdy, and E. S. A. Abdelmegeed, “Optimization of protease production by Ps. Aeruginosa PAO1 and Physico-chemical characterization of the enzyme,” Journal of American Science, vol. 10, no. 7, pp. 62–72, 2014. View at Google Scholar
  28. G. Rossignol, A. Merieau, J. Guerillon et al., “Involvement of a phospholipase C in the hemolytic activity of a clinical strain of Pseudomonas fluorescens,” BMC Microbiology, vol. 8, article 189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. D. K. Morales, N. J. Jacobs, S. Rajamani, M. Krishnamurthy, J. R. Cubillos-Ruiz, and D. A. Hogan, “Antifungal mechanisms by which a novel Pseudomonas aeruginosa phenazine toxin kills Candida albicans in biofilms,” Molecular Microbiology, vol. 78, no. 6, pp. 1379–1392, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. D. K. Morales, N. Grahl, C. Okegbe, L. E. P. Dietrich, N. J. Jacobs, and D. A. Hogan, “Control of Candida albicans metabolism and biofilm formation by Pseudomonas aeruginosa phenazines,” mBio, vol. 4, no. 1, Article ID e00526-12, 2013. View at Publisher · View at Google Scholar
  31. C. Cugini, D. K. Morales, and D. A. Hogan, “Candida albicans-produced farnesol stimulates Pseudomonas quinolone signal production in LasR-defective Pseudomonas aeruginosa strains,” Microbiology, vol. 156, no. 10, pp. 3096–3107, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. G. McAlester, F. O'Gara, and J. P. Morrissey, “Signal-mediated interactions between Pseudomonas aeruginosa and Candida albicans,” Journal of Medical Microbiology, vol. 57, no. 5, pp. 563–569, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. M. L. Langford, A. L. Atkin, and K. W. Nickerson, “Cellular interactions of farnesol, a quorum-sensing molecule produced by Candida albicans,” Future Microbiology, vol. 4, no. 10, pp. 1353–1362, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Koo, P. L. Rosalen, J. A. Cury, Y. K. Park, and W. H. Bowen, “Effects of compounds found in propolis on Streptococcus mutans growth and on glucosyltransferase activity,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 5, pp. 1302–1309, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. F. I. A. Gomes, P. Teixeira, J. Azeredo, and R. Oliveira, “Effect of farnesol on planktonic and biofilm cells of Staphylococcus epidermidis,” Current Microbiology, vol. 59, no. 2, pp. 118–122, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. H.-L. Alakomi, A. Paananen, M.-L. Suihko, I. M. Helander, and M. Saarela, “Weakening effect of cell permeabilizers on gram-negative bacteria causing biodeterioration,” Applied and Environmental Microbiology, vol. 72, no. 7, pp. 4695–4703, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. D. E. Woods, M. S. Schaffer, H. R. Rabin, G. D. Campbell, and P. A. Sokol, “Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites,” Journal of Clinical Microbiology, vol. 24, no. 2, pp. 260–264, 1986. View at Google Scholar · View at Scopus
  38. V. Majtán, A. Hostacká, A. Kosiarová, L. Majtánová, and S. Kohútová, “On the toxinogenicity of Pseudomonas aeruginosa strains,” Journal of Hygiene, Epidemiology, Microbiology, and Immunology, vol. 35, no. 2, pp. 217–224, 1991. View at Google Scholar
  39. J. L. Kadurugamuwa and T. J. Beveridge, “Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion,” Journal of Bacteriology, vol. 177, no. 14, pp. 3998–4008, 1995. View at Google Scholar · View at Scopus
  40. M. Kuroda, S. Nagasaki, R. Ito, and T. Ohta, “Sesquiterpene farnesol as a competitive inhibitor of lipase activity of Staphylococcus aureus,” FEMS Microbiology Letters, vol. 273, no. 1, pp. 28–34, 2007. View at Publisher · View at Google Scholar · View at Scopus